Transmembrane Transport of Ions and Small Molecules 11.1-11.2

Chapter 11: Transmembrane Transport of Ions and Small Molecules

11.1 Overview of Transmembrane Transport

  • Plasma Membrane Function:

    • Forms the barrier separating the cytoplasm from the external environment.

    • Defines physical and chemical boundaries within the cell.

    • Maintains differences in composition between cytosol and extracellular fluid.

    • Concentrations of ions:

    • Sodium ion ($[Na^+]_{cytosol}$) ~ 15 mM (inside cell) vs. 150 mM (extracellular fluid).

    • Potassium ion ($[K^+]_{cytosol}$) is ~ 150 mM (inside cell) vs. lower outside.

    • Critical for establishing the membrane potential.

  • Organelle Membranes:

    • Separate cytosol from organelles.

    • Example of differences in proton concentration: Lysosome interior has a pH of 5, much higher proton concentration than cytosol.

  • Membrane Composition:

    • All cellular membranes are composed of a bilayer of phospholipids embedded with proteins.

    • Phospholipid bilayers alone are impermeable to ions and large polar molecules, slightly permeable to water only.

  • Need for Selective Transport:

    • Membranes serve as conduits, selectively transporting essential molecules (like glucose) and exporting waste.

11.2 Facilitated Transport of Glucose and Water

  • Definition of Facilitated Transport:

    • Mechanism smartly designed for transporting glucose and other solutes across the plasma membrane more efficiently than simple diffusion.

  • Uniport Transport Characteristics:

    • Transport of a single molecule across a membrane via a uniporter is faster than simple diffusion.

    • Distinct properties of uniport:

    1. Faster than pure diffusion across pure phospholipid bilayer.

    2. No interaction with hydrophobic core of membrane.

    3. Limited number of uniporters establishes maximum transport rate ($V_{max}$).

    4. Transport direction depends on concentration gradient.

    5. Specificity for one type of molecule.

    • Example: GLUT1 transporter in mammalian cells, especially in erythrocytes.

11.3 ATP-Powered Pumps and the Intracellular Ionic Environment

  • Transport Mechanisms:

    • Cells require precise balance in import/export of molecules and ions.

    • Energy from ATP hydrolysis powers transport against concentration gradients.

    • Understand the alternating access model:

    • Highlights conformational change mechanism in transporter proteins.

    • Pumps, channels, and transporters vary in speed; Pumps are slower than channels due to single substrate movement.

  • Transport Types: (Based on energy usage and directionality)

    • Channels: High transport rate; allow ions/molecules to move down gradients.

    • Transporters: Medium transport rate; facilitate molecules moving predominantly down their gradients.

    • ATP-powered pumps: Slowest; use ATP to transport ions/molecules against gradients.

11.4 Nongated Ion Channels and the Resting Membrane Potential

  • Ionic Concentration:

    • Importance of maintaining gradients of ions across the membrane.

    • Examples of ionic gradients:

    • Sodium and potassium ions are unequal across membranes; potassium is abundant inside cells, while sodium is more outside.

11.5 Cotransport by Symporters and Antiporters

  • Cotransport Mechanisms:

    • Symporters: Move two molecules in the same direction; one against its gradient, another down its gradient (e.g., Glucose-Sodium symporter).

    • Antiporters: Move different molecules in opposite directions using similar gradient coupling.

11.6 Transcellular Transport

  • Importance of selective transport in cells for cellular function and adaptation to environments. Understanding membrane transport mechanisms is essential for comprehending disease-causing mutations and therapeutic developments.

  • Transmembrane Transport and Health:

    • Mutations in transport proteins can lead to diseases such as cystic fibrosis and long QT syndrome.

  • Recent advances in microscopy like cryo-EM are promising for future drug developments targeting transport proteins.